BPG is committed to discovery and dissemination of knowledge
- Number of total visits
-
32971479
- Number of visits today
- 4159
- Number of downloads
-
16137127
MEMBERSHIP
Cited by in F6Publishing
Number |
Citing Articles |
1 |
Cieślik M, Nazimek K, Bryniarski K. Extracellular Vesicles—Oral Therapeutics of the Future. IJMS 2022;23:7554. [DOI: 10.3390/ijms23147554] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
2 |
Krishnan N, Kubiatowicz LJ, Holay M, Zhou J, Fang RH, Zhang L. Bacterial membrane vesicles for vaccine applications. Adv Drug Deliv Rev 2022;185:114294. [PMID: 35436569 DOI: 10.1016/j.addr.2022.114294] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
3 |
Gorain C, Khan A, Singh A, Mondal S, Mallick AI. Bioengineering of LAB vector expressing Haemolysin co-regulated protein (Hcp): a strategic approach to control gut colonization of Campylobacter jejuni in a murine model. Gut Pathog 2021;13:48. [PMID: 34330327 DOI: 10.1186/s13099-021-00444-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
4 |
Cao H, Xu H, Ning C, Xiang L, Ren Q, Zhang T, Zhang Y, Gao R. Multi-Omics Approach Reveals the Potential Core Vaccine Targets for the Emerging Foodborne Pathogen Campylobacter jejuni. Front Microbiol 2021;12:665858. [PMID: 34248875 DOI: 10.3389/fmicb.2021.665858] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345